Gemcitabine hydrochloride lyophilized powder injection

A technology for gemcitabine hydrochloride and freeze-dried powder injection, which is applied in the field of gemcitabine hydrochloride freeze-dried powder for injection and its preparation, can solve the problems of lack of improvement, poor stability of gemcitabine hydrochloride, toxic and side effects, etc., and achieves considerable economic and social benefits, moisture drying Thorough, low levels of related substances

Active Publication Date: 2009-10-28
JIANGSU AOSAIKANG PHARMA CO LTD
0 Cites 33 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0005] Due to the poor stability of gemcitabine hydrochloride, it is easy to degrade and produce impurities that ...
View more

Abstract

The invention relates to a gemcitabine hydrochloride lyophilized powder injection and a preparation method thereof. The gemcitabine hydrochloride lyophilized powder injection prepared by the method can be used as a therapeutic medicament for treating middle and late non-small cell lung cancer, pancreatic cancer and the like. The gemcitabine hydrochloride lyophilized powder injection is characterized by consisting of gemcitabine hydrochloride, mannitol and sodium acetate, wherein the weight ratio of the gemcitabine hydrochloride to the mannitol is 1:0.5-5, and the weight ratio of the gemcitabine hydrochloride to the sodium acetate is 1:0.01-0.1. The preparation method comprises the following steps: taking the mannitol and the sodium acetate; dissolving the mannitol and the sodium acetate by adding injection water; adding the gemcitabine hydrochloride to the mixture, stirring and dissolving the mixture, and adjusting the pH to between 2.7 and 3.3; fixing the volume; filtering the product by a 0.22 mu m microporous membrane; filling, dishing up, lyophilizing, and compressing; taking the product out of a box, and tying the product with an aluminum-plastic composite cover; and inspecting the quality, and packaging the product after passing the quality inspection to obtain the gemcitabine hydrochloride lyophilized powder injection.

Application Domain

Powder deliveryOrganic active ingredients +3

Technology Topic

Pancreas CarcinomaDrug +7

Image

  • Gemcitabine hydrochloride lyophilized powder injection
  • Gemcitabine hydrochloride lyophilized powder injection

Examples

  • Experimental program(10)

Example Embodiment

[0019] Example 1:
[0020] prescription
[0021] Gemcitabine Hydrochloride 228g
[0022] Mannitol 228g
[0023] Sodium acetate 22.8g
[0024] Add water for injection to 6000ml
[0025]
[0026] A total of 1000 bottles were made
[0027] Weigh mannitol and sodium acetate, add 80% water for injection, dissolve and stir evenly, then add gemcitabine hydrochloride, dissolve and stir evenly, adjust pH to 2.7 with 0.1mol/L hydrochloric acid or 0.1mol/L sodium hydroxide solution, After passing the intermediate inspection, add water for injection to make up to full volume. The solution was sent to the sterile room by a peristaltic pump, filtered through a 0.22 μm microporous membrane until it was clear, filled in 25 ml vials with a volume of 6 ml per bottle, partially plugged with butyl rubber stoppers, and placed in a plate. Put the sample to be freeze-dried in the freeze-drying box, close the box door, turn on the machine, turn on the circulation pump, compressor and plate cooling valve, use heat transfer oil to lower the product temperature, and continue to freeze when the product temperature reaches -30°C. When the temperature of the product reaches about -40°C, close the plate cooling valve, turn on the electric heating and the automatic setting of the cold mixing valve, keep the temperature of the product for 3 hours, then open the condenser valve, and turn on the vacuum when the temperature of the condenser valve reaches -45°C System, when the vacuum of the front box reaches below 20Pa, it starts to heat up and sublimate and dry, and the final drying temperature is 30°C, keep this temperature for 3 hours, until the vacuum of the front box is closed and the septum valve is not significantly damaged, press the plug, take out the box, and use aluminum The plastic combination cover is tied up, and after passing the quality inspection, it is packaged and ready to be obtained.

Example Embodiment

[0028] Example 2:
[0029] prescription
[0030] Gemcitabine Hydrochloride 228g
[0031] Mannitol 114g
[0032] Sodium acetate 11.4g
[0033] Add water for injection to 6000ml
[0034]
[0035] A total of 1000 bottles were made
[0036] Weigh mannitol and sodium acetate, add 80% water for injection, dissolve and stir evenly, then add gemcitabine hydrochloride, dissolve and stir evenly, adjust pH to 3.3 with 0.1mol/L hydrochloric acid or 0.1mol/L sodium hydroxide solution, After passing the intermediate inspection, add water for injection to make up to full volume. The solution was sent to the sterile room by a peristaltic pump, filtered through a 0.22 μm microporous membrane until it was clear, filled in 25 ml vials with a volume of 6 ml per bottle, partially plugged with butyl rubber stoppers, and placed in a plate. Put the sample to be freeze-dried in the freeze-drying box, close the box door, turn on the machine, turn on the circulation pump, compressor and plate cooling valve, use heat transfer oil to lower the product temperature, and continue to freeze when the product temperature reaches -30°C. When the temperature of the product reaches about -40°C, close the plate cooling valve, turn on the electric heating and the automatic setting of the cold mixing valve, keep the temperature of the product for 2 hours, then open the condenser valve, and turn on the vacuum when the temperature of the condenser valve reaches -45°C System, when the vacuum of the front box reaches below 20Pa, it starts to heat up and sublimate and dry, and the final drying temperature is 30°C, keep this temperature for 4 hours, until the vacuum of the front box is closed and the septum valve is not significantly damaged, press the plug, take out the box, and use aluminum The plastic combination cover is tied up, and after passing the quality inspection, it is packaged and ready to be obtained.

Example Embodiment

[0037] Example 3:
[0038] prescription
[0039] Gemcitabine Hydrochloride 228g
[0040] Mannitol 1140g
[0041] Sodium acetate 11.4g
[0042] Add water for injection to 6000ml
[0043]
[0044] A total of 1000 bottles were made
[0045]Weigh mannitol and sodium acetate, add 80% water for injection, dissolve and stir evenly, then add gemcitabine hydrochloride, dissolve and stir evenly, adjust pH to 3.0 with 0.1mol/L hydrochloric acid or 0.1mol/L sodium hydroxide solution, After passing the intermediate inspection, add water for injection to make up to full volume. The solution was sent to the sterile room by a peristaltic pump, filtered through a 0.22 μm microporous membrane until it was clear, filled in 25 ml vials with a volume of 6 ml per bottle, partially plugged with butyl rubber stoppers, and placed in a plate. Put the sample to be freeze-dried in the freeze-drying box, close the box door, turn on the machine, turn on the circulation pump, compressor and plate cooling valve, use heat transfer oil to lower the product temperature, and continue to freeze when the product temperature reaches -30°C. When the temperature of the product reaches about -40°C, close the plate cooling valve, turn on the electric heating and the automatic setting of the cold mixing valve, keep the temperature of the product for 4 hours, then open the condenser valve, and turn on the vacuum when the temperature of the condenser valve reaches -45°C System, when the vacuum of the front box reaches below 20Pa, it starts to heat up and sublimate and dry, and the final drying temperature is 30°C, keep this temperature for 4 hours, until the vacuum of the front box is closed and the septum valve is not significantly damaged, press the plug, take out the box, and use aluminum The plastic combination cover is tied up, and after passing the quality inspection, it is packaged and ready to be obtained.

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Automatic pet feeder

ActiveUS20160007564A1improve stability
Owner:TONGFU MFG

Stamping equipment applied to motor rotor punching sheet production

Owner:SHENGZHOU LIDA ELECTRIC APPLIANCES FACTORY

Method for recycling manganese ion in electrolytic manganese production tail end wastewater

InactiveCN101838064AImprove stabilityReduce the number of operators
Owner:CHINESE RES ACAD OF ENVIRONMENTAL SCI

Coverage rate test processing method and device and coverage rate test server and system

ActiveCN103095518AImprove stabilityReduce the probability of failure
Owner:ALIBABA GRP HLDG LTD

Classification and recommendation of technical efficacy words

  • Improve stability
  • Low content of related substances

Docetaxel for injection and preparation method thereof

ActiveCN113975246ALow content of related substancesImprove stability
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products